About Mark Velleca
Form D filings for IMMvention Therapeutix in 2023 list Mark Velleca as director.
Mark Velleca first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Mark Velleca in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Mark Velleca works with at each company, as listed on that company's latest Form D.
IMMvention Therapeutix, Inc. · Form D, Jan 10, 2023
JT
Jenny Ting
Director
MT
Marilyn Thompson
Executive officer
AG
Anil Goyal
Chief Executive Officer and director
LO
Lev Osherovich
Director
BS
Benjamin Scruggs
Director
MC
Matthew Cohen
Director